Literature DB >> 33237545

Analysis of Antimicrobial Activity of Monocytic Myeloid-Derived Suppressor Cells in Infection with Mycobacterium tuberculosis and Human Immunodeficiency Virus.

Ankita Garg1.   

Abstract

Myeloid-derived suppressor cells (MDSC) encompass a subset of myeloid cells, which suppress both innate and adaptive immune functions. Since Mycobacterium tuberculosis (M. tuberculosis) can infect these cells, interest has emerged to study the antimicrobial response of MDSC to mycobacteria causing tuberculosis. Reactive oxygen species (ROS) are critical mediators to control intracellular replication of M. tuberculosis and MDSC express high levels of these effector molecules. Here we describe the flow cytometric assessment of total cellular ROS produced by MDSC in response to infection with M. tuberculosis and compare it with the ROS activity of non-MDSC myeloid cells. To further understand the dynamics of host-pathogen interactions, we provide details on methods for measurement of the intracellular replication of M. tuberculosis within MDSC. Of note, these procedures were adopted for primary MDSC and non-MDSC subsets isolated from human immunodeficiency virus (HIV)-uninfected or HIV-infected individuals, in vitro infected with M. tuberculosis to mimic M. tuberculosis mono- or HIV-M. tuberculosis coinfection, respectively.

Entities:  

Keywords:  Antimicrobial activity; Cell ROS; Flow cytometry; HIV-M. tuberculosis coinfection; MDSC sorting; Mitochondrial ROS; Monocytic MDSC

Year:  2021        PMID: 33237545      PMCID: PMC7845914          DOI: 10.1007/978-1-0716-1060-2_11

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  22 in total

1.  Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells.

Authors:  Melissa G Lechner; Daniel J Liebertz; Alan L Epstein
Journal:  J Immunol       Date:  2010-07-19       Impact factor: 5.422

2.  HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity.

Authors:  Ankita Garg; Stephen A Spector
Journal:  J Infect Dis       Date:  2013-09-01       Impact factor: 5.226

3.  Expansion of a subset of CD14highCD16negCCR2low/neg monocytes functionally similar to myeloid-derived suppressor cells during SIV and HIV infection.

Authors:  Lucio Gama; Erin N Shirk; Julia N Russell; Karina I Carvalho; Ming Li; Suzanne E Queen; Jorge Kalil; M Christine Zink; Janice E Clements; Esper G Kallas
Journal:  J Leukoc Biol       Date:  2012-02-24       Impact factor: 4.962

4.  Lung-residing myeloid-derived suppressors display dual functionality in murine pulmonary tuberculosis.

Authors:  Julia K Knaul; Sabine Jörg; Dagmar Oberbeck-Mueller; Ellen Heinemann; Lisa Scheuermann; Volker Brinkmann; Hans-Joachim Mollenkopf; Vladimir Yeremeev; Stefan H E Kaufmann; Anca Dorhoi
Journal:  Am J Respir Crit Care Med       Date:  2014-11-01       Impact factor: 21.405

Review 5.  HIV-1/mycobacterium tuberculosis coinfection immunology: how does HIV-1 exacerbate tuberculosis?

Authors:  Collin R Diedrich; Joanne L Flynn
Journal:  Infect Immun       Date:  2011-01-18       Impact factor: 3.441

6.  Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.

Authors:  Paola Filipazzi; Roberta Valenti; Veronica Huber; Lorenzo Pilla; Paola Canese; Manuela Iero; Chiara Castelli; Luigi Mariani; Giorgio Parmiani; Licia Rivoltini
Journal:  J Clin Oncol       Date:  2007-06-20       Impact factor: 44.544

7.  Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells.

Authors:  Cesar A Corzo; Matthew J Cotter; Pingyan Cheng; Fendong Cheng; Sergei Kusmartsev; Eduardo Sotomayor; Tapan Padhya; Thomas V McCaffrey; Judith C McCaffrey; Dmitry I Gabrilovich
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

Review 8.  Tuberculosis and HIV co-infection.

Authors:  Andrzej Pawlowski; Marianne Jansson; Markus Sköld; Martin E Rottenberg; Gunilla Källenius
Journal:  PLoS Pathog       Date:  2012-02-16       Impact factor: 6.823

Review 9.  The Emerging Role of Myeloid-Derived Suppressor Cells in Tuberculosis.

Authors:  Tandeka Magcwebeba; Anca Dorhoi; Nelita du Plessis
Journal:  Front Immunol       Date:  2019-04-30       Impact factor: 7.561

10.  MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis.

Authors:  Matthew J Delano; Philip O Scumpia; Jason S Weinstein; Dominique Coco; Srinivas Nagaraj; Kindra M Kelly-Scumpia; Kerri A O'Malley; James L Wynn; Svetlana Antonenko; Samer Z Al-Quran; Ryan Swan; Chun-Shiang Chung; Mark A Atkinson; Reuben Ramphal; Dmitry I Gabrilovich; Wesley H Reeves; Alfred Ayala; Joseph Phillips; Drake Laface; Paul G Heyworth; Michael Clare-Salzler; Lyle L Moldawer
Journal:  J Exp Med       Date:  2007-06-04       Impact factor: 14.307

View more
  2 in total

Review 1.  All trans retinoic acid as a host-directed immunotherapy for tuberculosis.

Authors:  Ahmad Z Bahlool; Conor Grant; Sally-Ann Cryan; Joseph Keane; Mary P O'Sullivan
Journal:  Curr Res Immunol       Date:  2022-03-30

2.  Antibody-Mediated LILRB2-Receptor Antagonism Induces Human Myeloid-Derived Suppressor Cells to Kill Mycobacterium tuberculosis.

Authors:  Vipul K Singh; Arshad Khan; Yitian Xu; Sunny Mai; Licheng Zhang; Abhishek Mishra; Blanca I Restrepo; Ping-Ying Pan; Shu-Hsia Chen; Chinnaswamy Jagannath
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.